BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12090325)

  • 1. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
    PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide survey on current treatments for IgA nephropathy in Japan.
    Matsuzaki K; Suzuki Y; Nakata J; Sakamoto N; Horikoshi S; Kawamura T; Matsuo S; Tomino Y
    Clin Exp Nephrol; 2013 Dec; 17(6):827-33. PubMed ID: 23519367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A glomerulonephropathy: A review.
    El Labban M; Surani S
    World J Clin Cases; 2024 Mar; 12(8):1388-1394. PubMed ID: 38576821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Caster DJ; Lafayette RA
    Am J Kidney Dis; 2024 Feb; 83(2):229-240. PubMed ID: 37742867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.
    Salvadori M; Rosso G
    World J Nephrol; 2016 Jan; 5(1):6-19. PubMed ID: 26788460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A young man with hematuria and difficulty urinating.
    Urban R; Olsen J; Foster T
    J Am Coll Emerg Physicians Open; 2021 Oct; 2(5):e12581. PubMed ID: 34746922
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative Comparison of the Clinical Efficacy of 6 Classes Drugs for IgA Nephropathy: A Model-Based Meta-Analysis of Drugs for Clinical Treatments.
    Yu J; Luo J; Zhu H; Sui Z; Liu H; Li L; Zheng Q
    Front Immunol; 2022; 13():825677. PubMed ID: 35419000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Zhang Z; Yang Y; Jiang SM; Li WG
    BMC Nephrol; 2019 Aug; 20(1):333. PubMed ID: 31455248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
    Masutani K; Tsuchimoto A; Yamada T; Hirakawa M; Mitsuiki K; Katafuchi R; Hirakata H; Kitazono T; Tsuruya K;
    Clin Exp Nephrol; 2016 Dec; 20(6):896-903. PubMed ID: 26758039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 10: Immunoglobulin A nephropathy.
    Kidney Int Suppl (2011); 2012 Jun; 2(2):209-217. PubMed ID: 25018935
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.
    Luo MN; Yao CW; Xu BH; Xu YZ; Liu WJ; Feng YM; Tao JL; Liu HF
    Exp Ther Med; 2014 Mar; 7(3):553-559. PubMed ID: 24520244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.
    Zhou YH; Tang LG; Guo SL; Jin ZC; Wu MJ; Zang JJ; Xu JF; Wu CF; Qin YY; Cai Q; Gao QB; Zhang SS; Yu DH; He J
    PLoS One; 2011 Apr; 6(4):e18788. PubMed ID: 21533280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroids and azathioprine in the treatment of IgA nephropathy.
    Stangou M; Ekonomidou D; Giamalis P; Liakou H; Tsiantoulas A; Pantzaki A; Papagianni A; Efstratiadis G; Alexopoulos E; Memmos D
    Clin Exp Nephrol; 2011 Jun; 15(3):373-380. PubMed ID: 21301920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
    Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
    J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine.
    Lim BJ; Kim JH; Hong SW; Jeong HJ
    Pediatr Nephrol; 2009 Mar; 24(3):513-9. PubMed ID: 19066978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
    Harmankaya O; Oztürk Y; Baştürk T; Obek A; Kiliçarslan I
    Int Urol Nephrol; 2002; 33(1):167-71. PubMed ID: 12090325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.